Display options
Cite
Yanik EL, Tamburro K, Eron JJ, et al. Recent cancer incidence trends in an observational clinical cohort of HIV-infected patients in the US, 2000 to 2011. Infect Agent Cancer. 2013;8(1):18doi: 10.1186/1750-9378-8-18.
Yanik, E. L., Tamburro, K., Eron, J. J., Damania, B., Napravnik, S., & Dittmer, D. P. (2013). Recent cancer incidence trends in an observational clinical cohort of HIV-infected patients in the US, 2000 to 2011. Infectious agents and cancer, 8(1), 18. https://doi.org/10.1186/1750-9378-8-18
Yanik, Elizabeth L, et al. "Recent cancer incidence trends in an observational clinical cohort of HIV-infected patients in the US, 2000 to 2011." Infectious agents and cancer vol. 8,1 (2013): 18. doi: https://doi.org/10.1186/1750-9378-8-18
Yanik EL, Tamburro K, Eron JJ, Damania B, Napravnik S, Dittmer DP. Recent cancer incidence trends in an observational clinical cohort of HIV-infected patients in the US, 2000 to 2011. Infect Agent Cancer. 2013 May 24;8(1):18. doi: 10.1186/1750-9378-8-18. PMID: 23705808; PMCID: PMC3671969.
Copy Download .nbib Format: NLM
Share it on

Infect Agent Cancer. 2013 May 24;8(1):18. doi: 10.1186/1750-9378-8-18.

Recent cancer incidence trends in an observational clinical cohort of HIV-infected patients in the US, 2000 to 2011.

Infectious agents and cancer

Elizabeth L Yanik, Kristen Tamburro, Joseph J Eron, Blossom Damania, Sonia Napravnik, Dirk P Dittmer

Affiliations

  1. Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, 715 Mary Ellen Jones Building, Chapel Hill, NC, USA. [email protected].

PMID: 23705808 PMCID: PMC3671969 DOI: 10.1186/1750-9378-8-18

Abstract

BACKGROUND: In HIV-infected populations in developed countries, the most recent published cancer incidence trend analyses are only updated through 2008. We assessed changes in the distribution of cancer types and incidence trends among HIV-infected patients in North Carolina up until 2011.

METHODS: We linked the University of North Carolina Center for AIDS Research HIV Clinical Cohort, an observational clinical cohort of 3141 HIV-infected patients, with the North Carolina Cancer registry. Cancer incidence rates were estimated across calendar years from 2000 to 2011. The distribution of cancer types was described. Incidence trends were assessed with linear regression.

RESULTS: Across 15,022 person-years of follow-up, 202 cancers were identified (incidence rate per 100,000 person-years [IR]: 1345; 95% confidence interval [CI]: 1166, 1544). The majority of cancers were virus-related (61%), including Kaposi sarcoma (N = 32) (IR: 213; 95%CI: 146, 301), non-Hodgkin lymphoma (N = 34) (IR: 226; 95%CI: 157, 316), and anal cancer (N = 16) (IR: 107; 95%CI: 61, 173). Non-Hodgkin lymphoma was observed to decrease from 2000 to 2011 (decline of 15 cases per 100,000 person-years per calendar year, 95%CI: -27, -3). No other changes in incidence or changes in incidence trends were observed for other cancers (all P > 0.20).

CONCLUSIONS: We observed a substantial burden of a variety of cancers in this population in the last decade. Kaposi sarcoma and non-Hodgkin lymphoma were consistently two of the greatest contributors to cancer burden across calendar time. Cancer rates appeared stable across calendar years, except for non-Hodgkin lymphoma, which appeared to decrease throughout the study period.

References

  1. Nat Med. 2006 Dec;12(12):1365-71 - PubMed
  2. AIDS. 2006 Aug 1;20(12):1645-54 - PubMed
  3. MMWR Suppl. 2011 Oct 7;60(4):64-9 - PubMed
  4. JAMA. 2012 Jul 25;308(4):387-402 - PubMed
  5. Stat Med. 2003 Oct 15;22(19):3055-71 - PubMed
  6. Lancet. 2009 Apr 18;373(9672):1352-63 - PubMed
  7. Cancer Chemother Pharmacol. 2011 Oct;68(4):827-33 - PubMed
  8. Cancer. 2012 Aug 15;118(16):3977-83 - PubMed
  9. J Natl Cancer Inst. 2011 May 4;103(9):753-62 - PubMed
  10. AIDS Res Hum Retroviruses. 2010 Aug;26(8):875-81 - PubMed
  11. N Engl J Med. 2009 Apr 30;360(18):1815-26 - PubMed
  12. Lancet Oncol. 2009 Apr;10(4):321-2 - PubMed
  13. CA Cancer J Clin. 2011 Mar-Apr;61(2):69-90 - PubMed
  14. Br J Cancer. 2010 Jul 27;103(3):416-22 - PubMed
  15. Adv Hematol. 2012;2012:485943 - PubMed
  16. Arch Intern Med. 2010 Aug 9;170(15):1337-45 - PubMed
  17. PLoS One. 2011;6(8):e17502 - PubMed
  18. Blood. 2012 Apr 12;119(15):3469-77 - PubMed
  19. AIDS Care. 2006;18 Suppl 1:S45-50 - PubMed
  20. Sex Transm Dis. 2006 Jul;33(7 Suppl):S32-8 - PubMed
  21. Cancer. 2011 Mar 1;117(5):1089-96 - PubMed
  22. Clin Infect Dis. 2012 Apr;54(7):1026-34 - PubMed
  23. Lancet. 1981 Sep 19;2(8247):598-600 - PubMed
  24. N Engl J Med. 1998 Apr 2;338(14):948-54 - PubMed
  25. N Engl J Med. 2008 Jan 31;358(5):535-6; author reply 536 - PubMed
  26. Int J Cancer. 2008 Jul 1;123(1):187-94 - PubMed
  27. Cancer. 2010 Dec 1;116(23):5507-16 - PubMed
  28. N Engl J Med. 1996 Jul 25;335(4):233-41 - PubMed

Publication Types

Grant support